| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-16,189 | -11,139 | -9,508 | 55,012 | -7,673 | -6,461 | -10,044 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Stock-based compensation expense | ||||||
2,344 | 1,781 | 1,810 | 907 | 880 | 718 | 225 |
Depreciation and amortization | ||||||
107 | 42 | 42 | 42 | 37 | 36 | 33 |
Change in fair value of warrant liability | ||||||
- | - | - | 0 | 0 | 2 | 5,450 |
Net amortization of premiums and discounts on short-term investments | ||||||
169 | 294 | 436 | 544 | 627 | 423 | 121 |
Changes in operating assets and liabilities: | ||||||
Research and development incentives receivable | ||||||
943 | 620 | 621 | 595 | -684 | -94 | 438 |
Prepaid expenses and other current assets | ||||||
-608 | 1,281 | 847 | 212 | -445 | 814 | 220 |
Operating lease, right-of-use-asset | ||||||
-171 | -165 | -85 | - | - | - | - |
Long term prepaid rent | ||||||
1,618 | 5,538 | 6,895 | - | - | - | - |
Accounts payable | ||||||
-1,685 | -4,664 | 3,764 | 641 | -671 | 409 | -259 |
Accrued expenses and other current liabilities | ||||||
1,112 | 1,554 | -885 | 475 | 650 | 62 | -1,479 |
Operating lease liabilities | ||||||
-159 | -53 | -91 | - | - | - | - |
Deferred rent | ||||||
- | - | - | -144 | 132 | -6 | -6 |
Net cash used in operating activities | ||||||
-15,735 | -19,973 | -13,582 | -6,033 | -6,103 | -6,383 | -6,859 |
Cash flows from investing activities: | ||||||
Purchases of property, plant and equipment | ||||||
4,056 | 784 | 362 | 1,848 | 633 | 3 | 116 |
Purchase of short-term investments | ||||||
88,983 | 12,142 | 18,486 | 55,307 | 23,774 | 100,106 | 10,744 |
Proceed from sales and maturities of short-term investments | ||||||
27,830 | 38,250 | 45,659 | 67,629 | 28,208 | 15,000 | 15,750 |
Net cash provided by (used in) investing activities | ||||||
-65,209 | 25,324 | 26,811 | 10,474 | 3,801 | -85,109 | 4,890 |
Cash flows from financing activities: | ||||||
Payment of issuance costs | ||||||
- | - | - | 0 | 0 | 1,962 | 195 |
Exercise of stock options | ||||||
357 | 105 | 18 | - | - | - | - |
Net cash provided by financing activities | ||||||
90,364 | 9,750 | 18 | 41 | 153 | 101,391 | -195 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
284 | -167 | -137 | 170 | -81 | -197 | -731 |
Net increase in cash, cash equivalents and restricted cash | ||||||
9,704 | 14,934 | 13,110 | 4,652 | -2,230 | 9,702 | -2,895 |
Supplemental disclosure of non-cash investing and financing activities: | ||||||
Net unrealized gain on short term investments | ||||||
- | - | 65 | - | - | - | - |
Deferred offering costs included in accounts payable | ||||||
- | - | - | - | - | - | 1,149 |
Purchases of property and equipment included in accounts payable | ||||||
- | - | - | - | - | - | 21 |
Lease assets obtained in exchange for new operating lease liabilities | ||||||
0 | 4,363 | 789 | - | - | - | - |